The National Institute on Aging (NIA), part of the National Institutes of Health (NIH), today announced that it is ending the intervention phase of the ASPirin in Reducing Events in the Elderly (ASPREE) trial, effective immediately. Study participants have been notified and instructed to stop taking the study medication: 100 mg of aspirin or placebo. The intervention phase was originally planned to finish in December 2017.
As we age, we all face more health conditions and treatments. To ensure they are getting good health care, it’s important for older adults to communicate effectively with their doctors and healthcare professionals. Help older adults make the most of their doctor’s appointments and communicate effectively with their healthcare providers with NIA’s Talking With Your Doctor Presentation Toolkit.
With shorter days and dropping temperatures, it is important to keep in mind that older adults are particularly vulnerable to the health risks that can come with cold weather. Hypothermia—a dangerous drop in core body temperature—can occur when it is too cold outside or the body is unable to produce the heat it needs to function. Older adults and those with chronic medical conditions are especially susceptible to hypothermia, even after relatively short exposure to cold weather or a small drop in body temperature.
Researchers from across the country will gather to discuss promising areas of research into age-related brain and cognitive changes, with a special focus on neuroplasticity, compensation, resilience, and reserve. The two-day meeting will build on priorities and research directions identified at the last two Cognitive Aging Summits held in 2007 and 2010.
On Sept. 16, 2016, in an effort to make information about clinical trials widely available to the public, the U.S. Department of Health and Human Services (HHS) issued a final rule specifying requirements for registering and reporting summary results information to ClinicalTrials.gov. The new rule expands the legal requirements for submitting registration and results information for certain clinical trials involving U.S. Food and Drug Administration (FDA)-regulated drug, biological and device products to ClinicalTrials.gov.
The National Institute on Aging (NIA) at the National Institutes of Health is partnering with the Morehouse School of Medicine to convene a regional workshop. This will be an opportunity to discuss NIA’s strategic directions for research on aging, learn more about research and training opportunities, and forge collaborations with investigators in the region who are conducting research on aging.